- Home
- BFRG vs CING Comparison
BFRG vs CING Comparison
Compare BFRG & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRG
- CING
- Stock Information
- Founded
- BFRG 2017
- CING 2012
- Country
- BFRG United States
- CING United States
- Employees
- BFRG N/A
- CING N/A
- Industry
- BFRG Retail: Computer Software & Peripheral Equipment
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- BFRG Technology
- CING Health Care
- Exchange
- BFRG Nasdaq
- CING Nasdaq
- Market Cap
- BFRG 14.8M
- CING 13.1M
- IPO Year
- BFRG 2023
- CING 2021
- Fundamental
- Price
- BFRG $1.76
- CING $4.25
- Analyst Decision
- BFRG
- CING Strong Buy
- Analyst Count
- BFRG 0
- CING 4
- Target Price
- BFRG N/A
- CING $30.67
- AVG Volume (30 Days)
- BFRG 941.1K
- CING 97.0K
- Earning Date
- BFRG 05-09-2025
- CING 05-07-2025
- Dividend Yield
- BFRG N/A
- CING N/A
- EPS Growth
- BFRG N/A
- CING N/A
- EPS
- BFRG N/A
- CING N/A
- Revenue
- BFRG N/A
- CING N/A
- Revenue This Year
- BFRG N/A
- CING N/A
- Revenue Next Year
- BFRG N/A
- CING N/A
- P/E Ratio
- BFRG N/A
- CING N/A
- Revenue Growth
- BFRG N/A
- CING N/A
- 52 Week Low
- BFRG $1.23
- CING $1.80
- 52 Week High
- BFRG $4.84
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- BFRG 50.52
- CING 56.43
- Support Level
- BFRG $1.55
- CING $4.03
- Resistance Level
- BFRG $1.78
- CING $4.61
- Average True Range (ATR)
- BFRG 0.25
- CING 0.31
- MACD
- BFRG 0.04
- CING 0.04
- Stochastic Oscillator
- BFRG 54.78
- CING 70.25
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.